Food Effect Study of CTP-543 in Healthy Volunteers
NCT03880136 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 14
Last updated 2019-06-13
Summary
Two period crossover study to assess the bioavailability of CTP-543 under fed and fasted conditions.
Conditions
- Healthy
Interventions
- DRUG
-
CTP-543
Once daily dosing
Sponsors & Collaborators
-
Concert Pharmaceuticals
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-03-25
- Primary Completion
- 2019-04-05
- Completion
- 2019-04-05
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Study of Bioavailability and Food Effect of SACT-1 and Edurant® Tablets in Healthy Adult Volunteers
NCT05358756 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Food Influences the Amount of BI 1291583 in the Blood of Healthy Men
NCT03837964 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of BI 1356 Administered With and Without Food to Healthy Male and Female Subjects
NCT02183493 ·Status: COMPLETED ·Phase: PHASE1
-
TMC435-TiDP16-C116 - Relative Bioavailability and Food Effect Study
NCT01308606 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Food Effect on Relative Bioavailability of RP6530 in Healthy Volunteers
NCT02690727 ·Status: COMPLETED ·Phase: PHASE1
-
A Open-label Study to Evaluate the Relative Bioavailability of Samatasvir (IDX184) and Food Effect in Healthy Male Participants (MK-2355-006)
NCT01335607 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the PK, Relative Bioavailability and Safety of TG-2349 With Single Oral Dose Under Fed Condition in Healthy Volunteers
NCT02108418 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I, Open Label,Crossover Food-Effect and Absolute Bioavailability Study of WCK2349 and WCK771 in Healthy Adult Human Volunteers
NCT01875939 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Relative Bioavailability of a New CC-220 Capsule Formulation, Compared to a Reference CC-220 Capsule Formulation, in Healthy Adult Subjects
NCT03135509 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability and Effect of Food on TAK-385 Tablet Formulations in Healthy Participants
NCT02396147 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single Ascending Doses of CC-92480 in Healthy Subjects
NCT03803644 ·Status: COMPLETED ·Phase: PHASE1
-
TMC435-TiDP16-C121: A Study Comparing 2 Tablet Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Effect of Food on Blood Levels of TMC435
NCT01022125 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Different Forms of BGB-43395 and Food Effect in Healthy Participants
NCT06761898 ·Status: COMPLETED ·Phase: PHASE1
-
Single-Dose PK and Safety Study of GBT440 in Subjects With Hepatic Impairment
NCT03114540 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation and Strength of Suzetrigine
NCT06336096 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Bioavailability Comparison of Two Different Formulations of MNTX Tablets
NCT01366352 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability and Food Effect Following Single Oral Dose of Darigabat Tablet Formulations in Healthy Participants
NCT05123079 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy People to Compare 2 Different Formulations of BI 1358894 Tablets Taken With or Without Food
NCT05155306 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 113823 Powder in Bottle (PiB) and Tablet in Healthy Male Volunteers
NCT02259972 ·Status: COMPLETED ·Phase: PHASE1
-
A Bioavailability and Food Effect Study of AZD5462 in Healthy Volunteers
NCT05512806 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test if Taking Different Formulations of BI 1358894 With or Without Food Influences the Amount of BI 1358894 in the Blood
NCT03892616 ·Status: COMPLETED ·Phase: PHASE1
-
A Relative Bioavailability Study and Food Effect Study of AB521 in Healthy Adult Volunteers
NCT05999513 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability Study of 4 Different Formulations of PF-07321332 Relative to the Commercial Tablet Formulation
NCT05263895 ·Status: COMPLETED ·Phase: PHASE1
-
Assess the Oral Bioavailability of a New ABT-263 Formulation in Healthy Female Subjects
NCT01053520 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Relative Bioavailability and Food-Effect of HA121-28 Tablet B in Healthy Subjects
NCT05072535 ·Status: COMPLETED ·Phase: PHASE1